| 1KCT | A:28-391 | ALPHA1-ANTITRYPSIN |
| 1OO8 | A:28-391 | CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION |
| 1OPH | A:28-391 | NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN |
| 1PSI | A:28-391 | INTACT RECOMBINED ALPHA1-ANTITRYPSIN MUTANT PHE 51 TO LEU |
| 1QLP | A:28-391 | 2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A CANONICAL TEMPLATE FOR ACTIVE SERPINS |
| 1QMB | B:353-391; B:353-391 | CLEAVED ALPHA-1-ANTITRYPSIN POLYMER |
| 2QUG | A:28-391 | CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN, CRYSTAL FORM A |
| 3NDD | B:359-391; B:359-391 | CLEAVED ANTITRYPSIN WITH P10 PRO, AND P9-P6 ASP |
| 3NDF | B:361-391; B:361-391 | CLEAVED ANTITRYPSIN WITH P8-P6 ASP |
| 1QMN | A:28-395 | ALPHA1-ANTICHYMOTRYPSIN SERPIN IN THE DELTA CONFORMATION (PARTIAL LOOP INSERTION) |
| 2WXW | A:76-448 | CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN |
| 2X0B | H:76-448; H:76-448; H:76-448; H:76-448 | CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN |
| 1NQ9 | L:53-429; L:53-429 | CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE |
| 1OYH | L:53-429; L:53-429 | CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN |
| 1SR5 | A:53-429 | ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE |
| 1T1F | C:53-429; C:53-429; C:53-429 | CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM |
| 2ZNH | B:53-429; B:53-429 | CRYSTAL STRUCTURE OF A DOMAIN-SWAPPED SERPIN DIMER |
| 3KCG | I:53-429 | CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA-PENTASACCHARIDE COMPLEX |
| 2VDX | B:19-382; B:19-382 | CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN |
| 2VDY | B:19-382; B:19-382 | CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL |
| 1JMJ | B:110-477; B:110-477 | CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II |
| 1JMO | A:110-477 | CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II-S195A THROMBIN COMPLEX |
| 2OAY | A:122-476 | CRYSTAL STRUCTURE OF LATENT HUMAN C1-INHIBITOR |
| 1LQ8 | H:359-387; H:359-387; H:359-387; H:359-387; H:359-387; H:359-387; H:359-387; H:359-387 | CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR |
| 2OL2 | B:27-387; B:27-387 | HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21 |
| 1LJ5 | A:10-379 | 1.8A RESOLUTION STRUCTURE OF LATENT PLASMINOGEN ACTIVATOR INHIBITOR-1(PAI-1) |
| 1OC0 | A:10-379 | PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN OF VITRONECTIN |
| 3PB1 | I:10-379 | CRYSTAL STRUCTURE OF A MICHAELIS COMPLEX BETWEEN PLASMINOGEN ACTIVATOR INHIBITOR-1 AND UROKINASE-TYPE PLASMINOGEN ACTIVATOR |
| 3Q02 | B:10-379; B:10-379 | CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION. |
| 3Q03 | B:10-379; B:10-379 | CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION. |
| 1JRR | P:367-380; P:367-380 | HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETIONMUTANT] COMPLEXED WITH PEPTIDE MIMICKING THE REACTIVE CENTER LOOP |
| 2ZV6 | C:6-390; C:6-390; C:6-390 | CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1 |
| 1WZ9 | B:6-375; B:6-375 | THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN |
| 1XQG | B:6-375; B:6-375 | 3.10 A CRYSTAL STRUCTURE OF MASPIN, SPACE GROUP P 4 21 2 |
| 1XU8 | B:6-375; B:6-375 | THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN |
| 2RIV | B:362-392; B:362-392 | CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN |
| 2RIW | B:362-392; B:362-392 | THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN COMPLEXED WITH THYROXINE |
| 2XN3 | B:361-392; B:361-392 | CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH MEFENAMIC ACID |
| 2XN5 | B:362-392; B:362-392 | CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH FUROSEMIDE |
| 2XN6 | B:362-392; B:362-392 | CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN |
| 2XN7 | B:362-392; B:362-392 | CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN (T405-CF) |
)
)